Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.99 USD
Change Today +0.12 / 4.18%
Volume 717.9K
RIGL On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ryan D. Maynard

Chief Financial Officer and Executive Vice President,Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Ryan D. Maynard has been the Chief Financial Officer of Rigel Pharmaceuticals Inc. since January 2007. Mr. Maynard has been an Executive Vice President of Rigel Pharmaceuticals, Inc. since June 2010. He served as Acting Chief Financial Officer and Vice President of Finance at Rigel Pharmaceuticals, Inc. since June 2006. He served as Vice President of Finance and Acting Chief Financial Officer of Rigel Pharmaceuticals, Inc. since June 1, 2006. He joined Rigel in September ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

Director and Chairman of Audit Committee


Santa Clara University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$441,345

Stock Options*

All Other Compensation$3,006
Exercisable Options1,003,206
Unexercisable Options227,605
Total Number of Options1,230,811

Total Compensation*

Total Annual Cash Compensation$444,351
Total Short Term Compensation$441,345
Other Long Term Compensation$3,006
Total Calculated Compensation$1,097,926
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.99 USD +0.12


Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at